WHO ICTRP trial
Study on the Efficacy and Safety of Short-Course Telitacicept in Sjögren's…
ChiCTR2600117190 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2600117190 |
|---|---|
| Public title | Study on the Efficacy and Safety of Short-Course Telitacicept in Sjögren's Syndrome |
| Scientific title | Study on the Efficacy and Safety of Short-Course Telitacicept in Sjögren's Syndrome |
| Primary sponsor | The First Affiliated Hospital of Nanchang University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Sjögren's Syndrome |
| Interventions | Experimental Group:Experimental Group: Telitacicept 160mg subcutaneously injected once weekly for 12 consecutive weeks, followed by drug withdrawal and continued follow-up until Week 24. ;Control Group:Control Group: Hydroxychloroquine… |
| Registration date | Jan 21, 2026 |
| Target size | Experimental Group:30;Control Group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: